Analyst Emily Bodnar works at HC WAINWRIGHT and is covering the the Healthcare sector with 72 price targets and ratings documented since 2022 spanning on 14 stocks.
Emily Bodnar's average stock forecast success ratio is 13.46% with an average time for price targets to be met of 22.85 days.
Most recent stock forecast was given on NVCR, NovoCure at 06-Jun-2023.
Analyst best performing recommendations are on VTYX.
The best stock recommendation documented was for VTYX at 9/1/2022. The price target of $36 was fulfilled within 11 days with a profit of $14.01 (63.71%) receiving and performance score of 57.92.
Average potential price target upside
Currently, out of the existing stock ratings of Emily Bodnar - 36 which are a Buy (90%), 4 which are a Hold (10%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
60
$27.04 (82.04%)
60
29 days ago
1/6 (16.67%)
$27.21 (100.75%)
85
Buy
77
$44.04 (133.62%)
46
7 months 30 days ago
0/2 (0%)
$29.39 (91.18%)
Buy
75
$42.04 (127.55%)
55
7 months 30 days ago
0/3 (0%)
$35.49 (140.03%)
Buy
54
$21.04 (63.83%)
37
7 months 30 days ago
1/2 (50%)
$14.99 (55.51%)
34
41
$8.04 (24.39%)
1 years 7 months 29 days ago
1/1 (100%)
$16.77 (69.21%)
366
